UB Study IDs Myelination ‘Master Switch,’ Could Aid MS Treatment

Updated July 16, 2014

Fraser J. Sim, PhD, assistant professor of pharmacology and toxicology, and his team have identified SOX10 as the single transcription factor that initiates the critical myelination process in the brain.

7/3/14 MS Stem Therapy May Benefit From UB Study [MS News Today]
7/2/14 UB SOX10 Study Published in PNAS [Medical News Today]
7/2/14 SOX10 Expedites Transformation From Progenitor to Myelin-Producing Cell [Rehab Management]
7/1/14 Increasing SOX10 Expression Will Likely Improve Transplant Therapy [Genetic Engineering News]
6/30/14 Goal is to Induce SOX10 in MS Patients [Medical XPress]
6/30/14 Finding May Speed Production of Treatment Cells [Science Codex]
6/30/14 Switching On SOX10 May Help Overcome Obtacles to Viable MS Stem Cell Treatment [Health Canal]
6/30/14 Only SOX10 Switched From Neural to Oligodendrocyte Progenitor Cell [Science Daily]